Peer Review reports
From: Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
| Original Submission | ||
|---|---|---|
| 20 Jan 2024 | Submitted | Original manuscript |
| 11 Mar 2024 | Reviewed | Reviewer Report - Gaetano Finocchiaro |
| 12 Mar 2024 | Reviewed | Reviewer Report |
| 7 Apr 2024 | Author responded | Author comments - Junping Zhang |
| 21 Apr 2024 | Reviewed | Reviewer Report - Nobuhiro Hata |
| 30 Apr 2024 | Reviewed | Reviewer Report - Gaetano Finocchiaro |
| 8 May 2024 | Author responded | Author comments - Junping Zhang |
| Resubmission - Version 2 | ||
| 7 Apr 2024 | Submitted | Manuscript version 2 |
| 10 May 2024 | Author responded | Author comments - Junping Zhang |
| Resubmission - Version 3 | ||
| 10 May 2024 | Submitted | Manuscript version 3 |
| Publishing | ||
| 10 May 2024 | Editorially accepted | |
| 21 Jun 2024 | Article published | 10.1186/s12885-024-12373-9 |
You can find further information about peer review here.